Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Achillion Pharmaceuticals completes $55.3mm IPO

Executive Summary

Completing an IPO it filed for in April, anti-infectives developer Achillion Pharmaceuticals has netted $55.3mm selling about 5.2mm common shares, including the overallotment. The shares were priced at $11.50, below the range of $14-16 the company estimated in September.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies